University of Florida

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).

1,106 total trials 170 currently recruiting 754 completed early-phase tilt top decile by trial count

University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.

University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.

Top-decile sponsor footprint

University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,106 total, page 7 of 23

COMPLETED NA

Healthy Aging Through Movement

NCT05772884

COMPLETED Phase 4

Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

NCT05209867

COMPLETED Phase 4

Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome

NCT05292755

COMPLETED NA

Effect of NNS on Metformin/GDF15, Pilot

NCT05400863

TERMINATED NA

Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus

NCT05379725

TERMINATED Phase 2

A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial

NCT04786600

TERMINATED Phase 4

Fycompa in Catamenial Epilepsy

NCT05201703

TERMINATED Phase 2

Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission

NCT04914676

COMPLETED

Respiratory-Swallow Coordination in Cardiothoracic Surgical Patients

NCT05173207

COMPLETED NA

Feasibility and Effectiveness of a Telehealth-Delivered Inductive Reasoning Training Program for Older Adults

NCT05334186

COMPLETED NA

AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid

NCT04463719

COMPLETED NA

Mixed-reality REBOA Simulator With Virtual Coaching

NCT05062928

COMPLETED NA

Stress and Sleep Study

NCT05218109

COMPLETED NA

Infant and Parent Shared Book Reading

NCT04337372

COMPLETED NA

Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation

NCT04916444

TERMINATED Phase 1

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

NCT04963413

COMPLETED NA

Improving Lactation Success in Black Mothers of Critically Ill Infants

NCT05147987

COMPLETED NA

Combined CBIT and rTMS to Improve Tourette's Syndrome

NCT04795908

TERMINATED Phase 4

BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia

NCT05102162

COMPLETED NA

HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity in SNAP-Education

NCT05019339

COMPLETED NA

EMPOWER: Empowering the Management of Pain-Obesity-Weight Through Enhanced Reward

NCT04851587

COMPLETED NA

The Effect of Tapping in the Venous Dilatation for Peripheral IV Access

NCT05265481

COMPLETED Early Phase 1

u-STOP LVAD Bleed: Utilization of Umbilical Cord Lining Stem Cells (ULSCs) To Prevent Left Ventricular Assist Device (LVAD) Associated Angiodysplastic Bleeding

NCT04811261

TERMINATED NA

Does Prehabilitation Improve Outcomes in Patients Undergoing Complex Spine Fusion Surgery?

NCT05034341

COMPLETED NA

Study of Pain Catastrophizing-2 (SPAC-2)

NCT04805190

COMPLETED NA

The Effects of Vibrotactile Stimulation in Patients With Movement Disorders

NCT05106816

COMPLETED Early Phase 1

Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)

NCT04723303

COMPLETED NA

Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia

NCT05032573

COMPLETED Phase 2

VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa

NCT04772547

COMPLETED NA

Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study

NCT05055362

COMPLETED Phase 2

Low Dose ICG for Biliary Tract and Tumor Imaging

NCT04942665

COMPLETED NA

Respiratory Strength Training in Cardiac Surgical Patients

NCT04887415

COMPLETED Phase 2

Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma

NCT04850222

COMPLETED Phase 4

Treatment of Pruritus With Intramuscular Promethazine

NCT04805073

COMPLETED Phase 1

Breathing and Attention Training for Chronic Low Back Pain

NCT04740710

COMPLETED NA

Effect of Total Sleep Deprivation on Vascular Function

NCT04535219

COMPLETED NA

A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans

NCT04705363

COMPLETED NA

The BE WITH Project: A Partially Nested Randomized Control Trial (PN-RCT)

NCT07204444

COMPLETED NA

Extension for Community Health Outcomes (ECHO) Diabetes Program

NCT06552923

COMPLETED NA

Smoking Prevention Through Social Connections Among Adolescents - ASPIRE

NCT02703597

TERMINATED

Apraxia in Parkinson's Disease Patients With Deep Brain Stimulation

NCT04725773

TERMINATED NA

Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device

NCT04743206

COMPLETED NA

The Effect of Psyllium and Wheat Bran on Body Weight in People With Parkinson's Disease and Constipation Symptoms

NCT04829760

COMPLETED NA

Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients

NCT04630093

TERMINATED NA

Cognitive Enhancement Through Computerized Training

NCT04244032

TERMINATED NA

Photobiomodulation for the Management of Temporomandibular Disorder Pain

NCT04415281

COMPLETED

Improving Diagnostic Standards in Dysphagia

NCT04773184

COMPLETED NA

Women Helping Women - Lung Cancer Screening

NCT04983134

COMPLETED NA

Preventing Weight Gain Among Those Who Decline Behavioral Weight Loss Treatment (STEADY)

NCT04751656

COMPLETED NA

Recipe for Heart Health

NCT04828447

← Previous Page 7 of 23 Next →

Phase Distribution

PhaseTrial count
Phase 1 123
Phase 2 109
Phase 3 13
Phase 4 90

What is open in the University of Florida pipeline

170 recruiting of 1,106 indexed (15% open); 754 completed (68%).

Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).

Top condition: Coronary Artery Disease (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Florida: open-pipeline peers nationwide

Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 8%10%12%14%16%18%20% Total trials Recruiting share University of FloridaUniversity of North Carolina, Chapel HillWake Forest University Health SciencesUniversity of Alabama at BirminghamNYU Langone HealthArrowhead Regional Medical CenterAurinia PharmaceuticalsBronx VA Medical CenterCandel Therapeutics
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,106 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this University of Florida page

1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.

  • 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.